Ekinci, AlperKilic, Sevilay O.Demir, NesrinSiddikoglu, Duygu2025-01-272025-01-2720240019-51541998-3611https://doi.org/10.4103/ijd.ijd_470_23https://hdl.handle.net/20.500.12428/28779Background: Rosacea is a chronic inflammatory skin disease. Previous studies have determined that IL-36, IL-37, and IL-38 may play a role in the pathogenesis of various inflammatory diseases. Aims and Objectives: The present study aims to evaluate the relationship of these cytokines with rosacea. Materials and Methods: A total of 100 individuals, including 50 patients with rosacea and 50 healthy controls, were included in the study. IL-36, IL-37, and IL-38 levels were measured using the ELISA method by taking serum samples from all participants. Results: The mean serum levels of IL-36, IL-37, and IL-38 in the patient group were 52.17 +/- 24.07 pg/ml, 18.46 +/- 8.18 pg/ml, and 25.74 +/- 8.36 ng/l, respectively. The mean serum levels of IL-36, IL-37, and IL-38 in the control group were 32.99 +/- 19.90 pg/ml, 44.61 +/- 22.27 pg/ml, and 45.61 +/- 17.32 ng/l, respectively. The difference between the serum levels of IL-36, IL-37, and IL-38 in the patient and control groups was statistically significant (P < 0.001). Conclusion: Based on these findings, an increase in IL-36 and a decrease in IL-37 and IL-38 may contribute to the pathogenesis of rosacea. Future rosacea treatments could target and/or interact with these possible steps in the pathogenesis of rosacea.eninfo:eu-repo/semantics/openAccessInflammationinterleukin-36interleukin-37interleukin-38rosaceaArticle69323223710.4103/ijd.ijd_470_23N/AWOS:0013697802000242-s2.0-8519757750039119329Q3